Ticker

Analyst Price Targets — BCAL

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
October 29, 2025 1:24 pmGary TennerD.A. Davidson$21.00$18.71StreetInsider Southern California Bancorp (BCAL) PT Raised to $21 at DA Davidson
August 4, 2025 11:32 amStephens$19.00$14.99TheFly California Bancorp upgraded to Overweight from Equal Weight at Stephens

Latest News for BCAL

California BanCorp (NASDAQ:BCAL) Given Average Rating of “Moderate Buy” by Brokerages

California BanCorp (NASDAQ: BCAL - Get Free Report) has received an average recommendation of "Moderate Buy" from the five analysts that are covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, three have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The

Defense World • Mar 1, 2026
Critical Survey: California BanCorp (NASDAQ:BCAL) versus Bank of Santa Clarita (OTCMKTS:BSCA)

Bank of Santa Clarita (OTCMKTS:BSCA - Get Free Report) and California BanCorp (NASDAQ: BCAL - Get Free Report) are both finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, profitability, risk, analyst recommendations, institutional ownership, dividends and earnings. Earnings and Valuation This table compares

Defense World • Feb 16, 2026
Critical Comparison: California BanCorp (NASDAQ:BCAL) vs. Bank of Santa Clarita (OTCMKTS:BSCA)

Bank of Santa Clarita (OTCMKTS:BSCA - Get Free Report) and California BanCorp (NASDAQ: BCAL - Get Free Report) are both finance companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, valuation, dividends, profitability, analyst recommendations and institutional ownership. Analyst Recommendations This is a breakdown

Defense World • Feb 10, 2026
Obagi Medical and DermFx Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

DermFx selected as a leading regional med spa partner due to its commitment to exceptional patient care, aesthetic innovation, and excellence across Southern California practices DermFx selected as a leading regional med spa partner due to its commitment to exceptional patient care, aesthetic innovation, and excellence across Southern California practices

GlobeNewsWire • Feb 6, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for BCAL.

No House trades found for BCAL.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top